drugset / Trial / NCT05370599

Hypertension in Young Adults Trial

NCT05370599

Phase 2 Terminated 36 enrolled University of California, San Francisco
RandomizedFactorialOpen-labelTreatment

Summary

This is a pilot randomized controlled trial which will test the effect of 3 different anti-hypertensive agents and 3 different strategies of engaging young adults in home blood pressure monitoring on blood pressure control, with secondary outcomes focused on quality of life and adverse events.

Timeline

Start
2022-04-15
Primary completion
2026-01-07
Completion
2026-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 2.5 mg
Subject Chlorthalidone Other / unclassified 12.5 mg
Subject Losartan Other / unclassified 12.5 mg

Indications